Cystic Fibrosis Market Research Report - Global Forecast To 2022

Cystic Fibrosis Market Research Report - Global Forecast To 2022

ID: MRFR/HC/1293-CRR | July, 2017 | Region: Global | 85 pages | Cooked Research Reports

Cystic Fibrosis Market Information, by diagnostic test (immunoreactive trypsinogen (IRT) test, sweat chloride test, sputum test, chest X-ray, CT scan and pulmonary function test), by treatment (medical, surgical and others) by drug type (small molecules and biologics) - Forecast to 2022



Study objectives of Cystic Fibrosis Market:



  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the cystic fibrosis market

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by diagnostic test, by treatment, by drug type and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global cystic fibrosis market.




Cystic Fibrosis market, by Drug Type


Cystic Fibrosis market, by Drug Type 
Intended Audience:



  • Cystic fibrosis manufacturers & suppliers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Government Research Laboratories

  • Independent Research Laboratories

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Service Providers

  • Academic Institutes and Universities



Market Synopsis of Cystic Fibrosis Market:


Market Scenario:


Cystic fibrosis is a genetic condition that causes severe damage to the respiratory and digestive systems. The damage is often caused due to buildup of thick, sticky mucus in the organs. The most commonly affected organs by cystic fibrosis are lungs, pancreas, liver and intestines. Every year, approximately 1000 people are diagnosed with this serious condition in United States. Globally the market for cystic fibrosis is increasing rapidly. Globally the market for cystic fibrosis is expected to grow at the rate of about XX% from 2016 to 2022.



Key Finding:



  • The cystic fibrosis global market and is expected to reach $XX million by 2022.

  • Medical treatment holds the largest share of XX% of the market.

  • North America holds the largest market share of XX% of cystic fibrosis market and is anticipated to reach $XX million by the end of forecast period.

  • Globally, Asia-Pacific the fastest growing region and expected to grow at the rate of XX% during the forecast period.



Segments:                
                                                                                                                        


Cystic fibrosis market has been segmented on the basis of diagnostic test which comprises of immunoreactive trypsinogen (IRT) test, sweat chloride test, sputum test, chest X-ray, CT scan and pulmonary function test. On the basis of treatments, market is segmented into medical therapy, surgical treatment and others. On the basis of drug type, market is segmented into small molecules and biologics.



Regional Analysis of Cystic Fibrosis Market:               
       


Globally North America is the largest market for cystic fibrosis. Europe is the second-largest market. Furthermore Asia pacific market is expected to be the fastest growing market for cystic fibrosis.


 


Key Players for Cystic Fibrosis Market:

Some of the key players in this market are: Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, Genentech, Pharmaxis, Chiesi Farmaceutici, Forest Laboratories and others.         


 


The report for cystic fibrosis market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
TABLE OF CONTENTS

1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:

2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:

3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS

4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY

5.1 IMMUNOREACTIVE TRYPSINOGEN (IRT) TEST
5.2 SWEAT CHLORIDE TEST
5.3 SPUTUM TEST
5.4 CHEST X-RAY
5.5 CT SCAN
5.6 PULMONARY FUNCTION TEST

6.1 MEDICAL THERAPY
6.2 SURGICAL TREATMENT
6.3 OTHERS

7.1 SMALL MOLECULES
7.2 BIOLOGICS

8.1 NORTH AMERICA
8.1.1 INTRODUCTION
8.2 EUROPE
8.2.1 INTRODUCTION
8.3 ASIA-PACIFIC
8.3.1 INTRODUCTION
8.4 MIDDLE EAST & AFRICA
8.4.1 INTRODUCTION

9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
9.1.1 STRATEGIC PARTNERSHIP
9.1.2 MERGER & ACQUISITION

10.1 ABBVIE
10.1.1 OVERVIEW
10.1.2 PRODUCT OVERVIEW
10.1.3 FINANCIALS
10.1.4 KEY DEVELOPMENTS
10.2 CHIESI FARMACEUTICI
10.2.1 OVERVIEW
10.2.2 PRODUCT OVERVIEW
10.2.3 FINANCIALS
10.2.4 KEY DEVELOPMENTS
10.3 F. HOFFMANN-LA ROCHE
10.3.1 OVERVIEW
10.3.2 PRODUCT OVERVIEW
10.3.3 FINANCIALS
10.3.4 STRATEGY
10.3.5 KEY DEVELOPMENT
10.4 FOREST LABORATORIES
10.4.1 OVERVIEW
10.4.2 PRODUCT OVERVIEW
10.4.3 FINANCIALS
10.4.4 KEY DEVELOPMENTS
10.5 GENENTECH
10.5.1 OVERVIEW
10.5.2 PRODUCT OVERVIEW
10.5.3 FINANCIALS
10.5.4 KEY DEVELOPMENTS
10.6 GILEAD SCIENCES
10.6.1 OVERVIEW
10.6.2 PRODUCT OVERVIEW
10.6.3 FINANCIALS
10.6.4 STRATEGY
10.6.5 KEY DEVELOPMENTS
10.7 NOVARTIS
10.7.1 OVERVIEW
10.7.2 PRODUCT OVERVIEW
10.7.3 FINANCIALS
10.7.4 STRATEGY
10.7.5 KEY DEVELOPMENTS
10.8 PHARMAXIS
10.8.1 OVERVIEW
10.8.2 PRODUCT OVERVIEW
10.8.3 FINANCIAL
10.8.4 KEY DEVELOPMENTS
10.9 VERTEX PHARMACEUTICALS
10.9.1 OVERVIEW
10.9.2 PRODUCT OVERVIEW
10.9.3 FINANCIALS
10.9.4 KEY DEVELOPMENTS
10.10 OTHERS

TABLE 1 GLOBAL CYSTIC FIBROSIS MARKET, BY DIAGNOSTIC TEST, 2013-2022 (USD MILLION)
TABLE 2 GLOBAL CYSTIC FIBROSIS MARKET, BY TREATMENT, 2013-2022 (USD MILLION)
TABLE 3 GLOBAL CYSTIC FIBROSIS MARKET, BY DRUG TYPE, 2013-2022 (USD MILLION)
TABLE 4 GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, 2013-2022 (USD MILLION)

FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL CYSTIC FIBROSIS MARKET, BY DIAGNOSTIC TEST
FIGURE 4 GLOBAL CYSTIC FIBROSIS MARKET, BY TREATMENT
FIGURE 5 GLOBAL CYSTIC FIBROSIS MARKET, BY DRUG TYPE
FIGURE 6 GLOBAL CYSTIC FIBROSIS MARKET, BY REGION
FIGURE 7 GLOBAL CYSTIC FIBROSIS MARKET: COMPANY SHARE ANALYSIS, 2015 (%)